Zeaxanthin

Evidence Level
Moderate
5 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Zeaxanthin is a yellow-orange carotenoid and antioxidant that helps protect the eyes from oxidative stress and harmful blue light, playing a vital role in maintaining healthy vision and supporting the macula. It is naturally found in foods such as corn, orange and yellow peppers, goji berries, egg yolks, and leafy greens like spinach and kale. In supplements, zeaxanthin is most commonly sourced from marigold flower extract (Tagetes erecta) or produced through fermentation using specialized yeast strains. It is often combined with lutein in eye health formulas for their synergistic benefits.

Studied Dose 2–10 mg/day; AREDS2 formula uses 2 mg zeaxanthin + 10 mg lutein; combined lutein/zeaxanthin ratio 5:1 (lutein:zeaxanthin)
Active Compound Zeaxanthin (carotenoid)

Benefits

Eye Health Protection

Zeaxanthin, along with lutein, accumulates in the retina and macula, forming macular pigment that filters harmful blue light and protects against oxidative stress. This reduces the risk of age-related macular degeneration (AMD) and cataracts.

Antioxidant Properties

It neutralizes free radicals in the laboratory and may reduce oxidative damage in eye tissue. This is a measured mechanism, not a clinical outcome; effects on inflammation or long-term disease have not been tested in trials of zeaxanthin.

Improved Visual Function

Zeaxanthin may enhance visual acuity, contrast sensitivity, and glare recovery, supporting better vision in bright light or low-contrast conditions.

Cognitive Effects Not Established

Zeaxanthin is found in brain tissue, but no trials show that oral zeaxanthin improves memory or thinking, and it is not established to change the risk of any brain disease.

Skin: No Human Evidence

No trials have tested oral zeaxanthin for skin protection or skin health; any skin effect is mechanistic only.

Mechanism of action

1

Antioxidant Activity

Zeaxanthin, a carotenoid, absorbs high-energy blue light and quenches reactive oxygen species (ROS) in the retina, protecting photoreceptor cells from oxidative damage.

2

Macular Pigment Formation

It accumulates in the macula of the eye, forming a protective pigment layer with lutein. This filters blue light and reduces photo-oxidative stress, lowering the risk of age-related macular degeneration (AMD).

3

Anti-Inflammatory Effects

Zeaxanthin modulates inflammatory pathways, reducing cytokine production and inflammation in ocular and systemic tissues.

Clinical trials

1
Lutein + Zeaxanthin for AMD — AREDS2
PubMed

Multicenter clinical trial (NCT00345176, AREDS2) in 4,203 participants aged 50-85 with intermediate or advanced AMD. Tested lutein 10 mg + zeaxanthin 2 mg ± omega-3 vs original AREDS. (AREDS2 Research, JAMA)

4,203 adults with AMD risk.

In secondary analyses, lutein + zeaxanthin was associated with about 10% lower risk of progression to advanced AMD (hazard ratio 0.90); the primary randomized comparison did not reach statistical significance. When lutein/zeaxanthin replaced beta-carotene, formulation was safer (beta-carotene increased lung cancer risk in former smokers). Standard recommendation for intermediate AMD.

2
Lutein/Zeaxanthin Bioavailability — Japanese Clinical Trial

Clinical trial in 59 healthy adults aged 20-69 in Japan receiving 12 mg/day lutein vs placebo for 12 weeks.

59 healthy Japanese adults.

Modest macular pigment density increases vs placebo. Bioavailability/biomarker outcomes; clinical visual benefits less established in healthy populations.

3
Lutein/Zeaxanthin for Retinitis Pigmentosa — Clinical Trial
PubMed

Randomized, double-masked trial (NCT00346333) in 225 RP patients receiving vitamin A ± lutein/zeaxanthin.

225 RP patients.

Modest signal on visual field decline. RP is heterogeneous group of inherited retinal dystrophies; modern landscape includes voretigene neparvovec (Luxturna) for RPE65 mutations.

4
Lutein/Zeaxanthin/Omega-3 in AMD Family — LIMPIA Trial
PubMed

Clinical trial (NCT01269697, LIMPIA) in 120 first-generation offspring of parents with neovascular AMD.

120 AMD-family adults aged 18-50.

Modest increases in macular pigment and contrast sensitivity vs placebo. AMD-related visual function improvements may begin earlier in at-risk individuals.

5
Dose-Ranging Lutein/Zeaxanthin in Older Adults — Clinical Trial
PubMed

Clinical trial in 45 adults aged 60+ receiving lutein 2.5, 5, or 10 mg vs placebo.

45 older adults.

Dose-dependent serum carotenoid increases. Established dosing parameters. Common AMD trial dose: 10 mg lutein + 2 mg zeaxanthin.

Side effects and drug interactions

Common Potential side effects

Gastrointestinal Issues: Mild side effects such as nausea, stomach upset, or diarrhea may occur, particularly at higher doses (e.g., above 10–20 mg/day) or when taken without food.
Skin Discoloration: High doses may cause a harmless yellow or orange tint to the skin (carotenodermia), which is rare and reversible upon reducing intake.
Allergic Reactions: Rare allergic reactions, including rash, itching, or swelling, may occur, especially in individuals sensitive to carotenoids or zeaxanthin sources (e.g., marigold extract). Severe allergic reactions (e.g., anaphylaxis) are extremely rare but possible.

Important Drug interactions

Lutein supplements — synergistic combination; the two compete for the same dietary transport pathways at very high doses but are complementary at clinical doses
Fat-soluble vitamin supplements (A, D, E, K) — all compete for intestinal absorption pathways; spread out fat-soluble supplement intake
Orlistat — reduces absorption of all fat-soluble nutrients including carotenoids like zeaxanthin; take zeaxanthin 2 hours before orlistat dose

Frequently asked questions about Zeaxanthin

What is zeaxanthin used for?

Zeaxanthin is a carotenoid that, along with lutein, concentrates in the macula of the eye. It supports eye health, helps filter high-energy blue light, and is studied for protecting long-term vision. It is almost always paired with lutein.

How much zeaxanthin should I take?

The eye-health research (AREDS2) used 2 mg of zeaxanthin alongside 10 mg of lutein per day. This 10-to-2 lutein-to-zeaxanthin ratio is the standard evidence-based combination.

Should I take zeaxanthin with food?

Yes. Like other carotenoids, zeaxanthin is fat-soluble and absorbs best with a meal containing some fat. Daily consistency matters more than the exact timing.

Is zeaxanthin safe?

Zeaxanthin is generally very safe and well tolerated, with a long history in foods (it gives corn and peppers their color). It has a good safety record at supplemental doses used for eye health.

What is Zeaxanthin?

Zeaxanthin is a yellow-orange carotenoid and antioxidant that helps protect the eyes from oxidative stress and harmful blue light, playing a vital role in maintaining healthy vision and supporting the macula.

What is the recommended dosage of Zeaxanthin?

The clinically studied dose is 2–10 mg/day; AREDS2 formula uses 2 mg zeaxanthin + 10 mg lutein; combined lutein/zeaxanthin ratio 5:1 (lutein:zeaxanthin) Always follow the product label and check with a healthcare provider for personal advice.

Is Zeaxanthin safe, and does it have side effects?

For most healthy adults, Zeaxanthin is well tolerated at studied doses. Reported effects can include: Gastrointestinal Issues: Mild side effects such as nausea, stomach upset, or diarrhea may occur, particularly at higher doses (e.g., above 10–20 mg/day) or when taken without food. It may also interact with some medications. Zeaxanthin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Zeaxanthin interact with any medications?

Possible interactions include: Lutein supplements — synergistic combination; the two compete for the same dietary transport pathways at very high doses but are complementary at clinical doses Fat-soluble vitamin supplements (A, D, E, K) — all compete for intestinal absorption pathways; spread out fat-soluble s… If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Zeaxanthin?

NutraSmarts rates the evidence for Zeaxanthin as Moderate (3 out of 5). It is backed by 5 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Wang WX, Wang CC, Hsu WC, Peng YJ. From Supplements to Sight: Quantifying the Impact of Lutein and Carotenoid on Age-Related Macular Degeneration-A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Ophthalmol. 2026;2026:2155378..PubMedUsed to support: Systematic review and meta-analysis of randomized trials finding that lutein and related carotenoids (usually lutein together with zeaxanthin) are associated with benefit in age-related macular degeneration. The trials pooled mostly combine zeaxanthin with lutein, so this does not isolate zeaxanthin taken on its own.
  2. Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005-15. doi: 10.1001/jama.2013.4997.PubMedUsed to support: Large randomized trial (4,203 adults with AMD) of lutein 10 mg plus zeaxanthin 2 mg. The two carotenoids were tested together, not zeaxanthin alone. The primary comparison was not statistically significant; secondary analyses showed roughly a 10% lower risk of progression to advanced AMD, and substituting lutein/zeaxanthin for beta-carotene avoided the excess lung-cancer risk seen with beta-carotene in former smokers.
  3. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, Johnson EJ, Anderson EJ, Johnson CA, Gaudio AR, Willett WC, Schaefer EJ. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol. 2010;128(4):403-11. doi: 10.1001/archophthalmol.2010.32.PubMedUsed to support: Randomized double-masked trial in 225 patients with retinitis pigmentosa taking vitamin A, testing 12 mg/day of lutein (not zeaxanthin) over 4 years. It found a modest slowing of visual-field loss in some measures. Evidence is for lutein, in an inherited retinal disease, not for zeaxanthin in the general population.
  4. Korobelnik JF, Rougier MB, Delyfer MN, Bron A, Merle BMJ, Savel H, Chene G, Delcourt C, Creuzot-Garcher C. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and Omega-3 on Macular Pigment: A Randomized Clinical Trial. JAMA Ophthalmol. 2017;135(11):1259-1266. doi: 10.1001/jamaophthalmol.2017.3398.PubMedUsed to support: Randomized trial (LIMPIA) in 120 offspring of parents with neovascular AMD, testing a lutein, zeaxanthin and omega-3 combination. It found modest increases in macular pigment optical density versus placebo, a biomarker surrogate rather than a proven change in long-term vision. Zeaxanthin was co-administered with lutein and omega-3, not tested alone.